Blog

Robotic Pump Placement for Liver Metastasis Key to Minimally Invasive Approach

Minimally invasive robotic placement of hepatic artery infusion pumps shows promise for recurrent colorectal liver metastasis patients post-hemihepatectomy.

  • Operative time was 150 minutes with 75 ml blood loss.
  • Patient discharge occurred on day 3 with no complications.

Surgeons can consider this technique to enhance patient recovery while maintaining safety.

  • Postoperative scans confirmed optimal hepatic perfusion without extra-hepatic disease.

Journal Article by Bansal B, Ross S and Sucandy I in Ann Surg Oncol

© 2026. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Outcomes Similar for Immune Therapy After Nivolumab in Esophageal Cancer

First-line immune checkpoint inhibitor therapy for esophageal cancer recurrence shows no advantage based on prior adjuvant nivolumab treatment.

  • Among 81 patients, early tumor shrinkage rates were similar between those with and without prior nivolumab exposure.
  • No differences in progression-free survival (HR 1.4) or overall survival (HR 1.23), with 2-year overall survival at approximately 44%.

This suggests prior adjuvant immunotherapy does not hinder the effectiveness of subsequent treatments during recurrence.

Journal Article by Sugase T, Kanemura T (…) Miyata H et 17 al. in Ann Surg Oncol

© 2026. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Whole Blood Prehospital Transfusion Doesn’t Lower Mortality

Using whole blood for prehospital transfusions in trauma patients does not significantly decrease 30-day mortality compared to blood components.

  • 30-day mortality was 25.9% for whole blood vs. 20.5% for components (adjusted odds ratio 1.24, p=0.24).
  • No significant differences in adverse events between groups were noted.

Surgeons should consider these findings when deciding on prehospital transfusion strategies for hemorrhagic shock patients.

  • Storage age of whole blood (1-14 days vs. 15-21 days) did not impact 30-day mortality significantly.

Journal Article by Sperry JL, Guyette FX (…) Wisniewski SR et 28 al. in N Engl J Med

Copyright © 2026 Massachusetts Medical Society.

read the whole article in N Engl J Med

open it in PubMed

Reducing Postoperative Mortality in Low-Income Countries

Postoperative mortality is a major issue in low- and middle-income countries, and this review identifies key interventions that can help.

  • Eighteen trials with 95,521 patients were reviewed, revealing four that significantly reduced mortality, but results were context-specific.
  • Effective strategies included improved operative techniques in neurosurgery and enhanced blood management in Brazil.

Future efforts should focus on co-developing interventions tailored to specific regional needs, especially in sub-Saharan Africa.

  • Adherence to these interventions was high, averaging around 95%, emphasizing the potential for effective implementation.

Journal Article by Phelan LN, Agbeko AE (…) Glasbey J et 7 al. in Br J Surg

© The Author(s) 2026. Published by Oxford University Press on behalf of BJS Foundation Ltd.

read the whole article in Br J Surg

open it in PubMed

Surgical innovation drives precision and personalization in patient care.

  • Emerging technologies in surgery include micro/nanorobots and intelligent instruments aimed at enhancing minimally invasive procedures.
  • Use of translational genomics and artificial intelligence is expanding, improving diagnosis and treatment pathways for both benign and malignant diseases.

Surgeons should prioritize collaboration with engineers and scientists to leverage these advancements effectively.

  • Emphasizing ethical considerations and patient outcomes is crucial as we integrate new technologies into practice.

Review by Matthews JB, Ruurda JP (…) Hussein IFE et 28 al. in Br J Surg

© The Author(s) 2026. Published by Oxford University Press on behalf of BJS Foundation Ltd. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

read the whole article in Br J Surg

open it in PubMed

Multimodal Prehabilitation Cuts Complications in Colorectal Surgery

A national study shows that multimodal prehabilitation significantly reduces complications in colorectal cancer surgery, improving outcomes for patients.

  • Overall complication rates dropped from 37.8% to 30.1% in the prehabilitation group (odds ratio 0.71).
  • Medical complications decreased from 24.6% to 15.4% (odds ratio 0.56).
  • Length of hospital stay was reduced by 1 day, from 5 to 4 days (p < 0.001).

Implementing prehabilitation could enhance surgical recovery and reduce healthcare costs.

Journal Article by Sabajo CR, Ten Cate DWG (…) Slooter GD et 22 al. in JAMA Surg

read the whole article in JAMA Surg

open it in PubMed

Neoadjuvant Chemo May Not Improve Survival in Early PDAC

Neoadjuvant chemotherapy’s benefit in early-stage pancreatic ductal adenocarcinoma is questionable due to bias in survival estimates.

  • In a study of 13,466 patients, those receiving neoadjuvant chemotherapy showed initially longer median survival (33.4 vs. 25.7 months) but this disappeared after correcting for immortal time bias.
  • Three robust statistical methods revealed no significant survival advantage for neoadjuvant therapy compared to upfront surgery.

Surgeons should reconsider the routine use of neoadjuvant chemotherapy in this patient population, focusing on more reliable data for decision-making.

Journal Article by Ashraf Ganjouei A, Wang J (…) Adam MA et 7 al. in Ann Surg Oncol

© 2026. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Study finds no link between hernia mesh and autoimmune disease

Mesh implantation during hernia repairs does not increase the risk of developing autoimmune diseases compared to surgeries without mesh.

  • Incidence of new autoimmune disease was 1.1% for hernia patients and 1.5% for cholecystectomy controls, showing no statistically significant difference (p = 0.520).
  • This finding challenges fears surrounding mesh use, which may influence patient decision-making and reduce legal claims.

This research supports the continued use of polypropylene mesh in hernia repairs, reassuring both surgeons and patients.

Journal Article by Gielen MJCAM, Chaoui AM (…) Zwaans WAR et 6 al. in Br J Surg

© The Author(s) 2026. Published by Oxford University Press on behalf of BJS Foundation Ltd.
© The Author(s) 2026. Published by Oxford University Press on behalf of BJS Foundation Ltd.

read the whole article in Br J Surg

open it in PubMed

Laparoscopic Approach Safe for Large Hepatocellular Tumors

Laparoscopic anterior-approach right posterior sectionectomy is a safe option for hepatocellular carcinoma tumors over 10 cm.

  • Four patients with median tumor size of 11.5 cm underwent the procedure; all had negative margins.
  • Median operative time was 524 minutes with minimal blood loss (80 ml) and no transfusions.

This technique allows for secure transection without the need for mobilization, reducing complication risk and improving recovery times.

  • Post-operative stay averaged 11 days, with no serious complications reported.

Journal Article by Urade T, Kido M (…) Fukumoto T et 10 al. in Ann Surg Oncol

© 2026. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Fluorescence-Guided Remnant-Sparing Distal Pancreatectomy Shows Promise

Surgeons can safely perform a remnant-sparing distal pancreatectomy using fluorescence guidance for select patients with metachronous pancreatic cancer after Whipple procedure.

  • The procedure was completed in 123 minutes with only 20 ml of blood loss.
  • Post-op, the patient had a normal amylase level and was discharged by day 5 with no complications.

This approach preserves pancreatic function while effectively addressing oncology needs.

  • At six months, the patient remains recurrence-free and retains stable endocrine and exocrine functions.

Journal Article by Wiboonkhwan NA in Ann Surg Oncol

© 2026. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed